POSSIBLE ADVERSE EVENTS DURING IBD TREATMENT

sustained viral response and hematological adverse events during chronic hepatitis c infection treatment

Medical adverse events during patient’s hospitalization at training Hospitals in Kerman

  Introduction: Medical errors are one of important and noticeable challenges of health care, which threaten the health system of all countries. On the other hands this issue is a global, costly with serious complications for patients and society.   Objective: The present study aimed to determine the rate of medical adverse events during patients' hospitalization.   Methods...

Adverse events of sutures: possible interactions of biomaterials?

Absorbable sutures are in use for more than 30 years. Tissue reactions which might be associated with suture material have rarely been reported in the past. After a long period without complications caused by suture material we observed 12 cases of unexpected tissue reactions after clean operations. Our patients 3-8 weeks after uneventful elective clean operations (varicose vein, hernia, benign...

Adverse events of methotrexate treatment in JIA

Background Methotrexate (MTX) which has been used for 20 years in Juvenile Idiopathic Arthritis (JIA) has now become the first-choice, second-line agent for children with polyarticular course JIA. New biologic drugs are used for MTX-failing patients and have been assessed in controlled trials for effectiveness. Safety data of these drugs are slowly and selectively emerging as post-marketing dat...

Combination of thiopurines and allopurinol: adverse events and clinical benefit in IBD.

BACKGROUND AND AIMS Allopurinol has been presented as a safe and effective adjunct to thiopurine therapy in inflammatory bowel disease (IBD). We aimed to determine the rate of infectious complications and clinical successes with a combination of thiopurine/allopurinol in IBD, and to identify which variables predict 6-thioguanine, 6-methylmercaptopurine, and white blood cell levels. Additionally...